Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
“Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum

WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines.

Published
15 April 2019
From
Health Policy Watch
UN Whistleblower Targeted in Misconduct Probe

Confidential documents obtained by The Associated Press show UNAIDS is grappling with previously unreported allegations of financial and sexual misconduct involving Martina Brostrom, who went public last March with claims that one of the organization's top officials assaulted her in 2015. As part of a preliminary internal inquiry, investigators for the World Health Organization, which oversees UNAIDS, wrote that they had found "evidence" that Brostrom and her former supervisor may have taken part in "fraudulent practices and misuse of travel funds," the documents show.

Published
15 April 2019
From
U.S. News and World Report
Will new TB treatments reach those who need them most?

Pharma giant GlaxoSmithKline is pursuing new treatments for tuberculosis but insists it will need support from governments and funding agencies if it is to get them to patients in lower-income countries, the head of its global health unit, David Barros-Aguirre, told Devex.

Published
15 April 2019
From
Devex
Tackling the high price of medicine

Profit seems to be the only logic driving medicine prices, with some African countries paying more for medicine than European countries, and US citizens paying some of the highest medicine prices in the world. While there are global efforts to rein in pharmaceutical companies’ excessive profiteering from sickness, trying to remove the secrecy around prices is complicated.

Published
15 April 2019
From
Daily Maverick
London councils agree to take 60% new PrEP trial patients, but it might not be enough

A stalemate over who would take more patients on to PrEP trial has ended. London councils have agreed to increase places on city PrEP trial.

Published
15 April 2019
From
Gay Star News
Dovato Is a Newly Approved Two-Drug HIV Regimen. Do Fewer Drugs Mean a Lower-Cost HIV Treatment?

When HIV drugmaker ViiV announced in late 2017 that it had received Food and Drug Administration (FDA) approval for Juluca (dolutegravir/rilpivirine), the first effective two-drug, single-pill HIV regimen in the modern treatment era, community activists hoped that its price would reflect the fact that it contained one drug fewer than three-drug tablets like Complera (rilpivirine/tenofovir disoproxil fumarate/FTC), Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide), Stribild (cobicistat/elvitegravir/FTC/tenofovir disoproxil fumarate), and Triumeq (abacavir/dolutegravir/lamivudine), all of which are generally priced between $2,600 and $3,500 a month in the U.S.

Published
15 April 2019
From
The Body
South Africa: Health department scrambles to stop US cut in HIV funds

In a surprise move barely six weeks after announcing that SA was to get an extra $1.2bn to support its HIV/AIDS programmes over the next two years, US global AIDS coordinator Deborah Birx said Pepfar’s programmes are performing so poorly in SA that funding should be cut from the start of the next US financial year, which begins on October 1.

Published
12 April 2019
From
Business Day
Gilead Lawsuits: 41 HIV and PrEP Patients File California Personal Injury Case Over Gilead's TDF-Based Drugs

41 patients from 12 states nationwide who are living with HIV or AIDS or were on PrEP filed a personal injury lawsuit against Gilead Sciences Inc. seeking to hold the Bay Area drug maker accountable for actions around its failure to rectify a known defect in the drug formulation of one of its most widely prescribed medications: tenofovir disoproxil fumarate (TDF) knowing that a safer alternate, tenofovir alafenamide (TAF) existed in its own laboratory; its failure to warn patients of the damaging side effects of TDF; and the company’s active misrepresentation of TDF’s efficacy and substantial risks.

Published
12 April 2019
From
Associated Press
London: Tower Hamlets Mayor calls for Government to fund PrEP for all to stop HIV transmission

John Biggs, Mayor of Tower Hamlets has written to Matt Hancock the Secretary of State for health, to call for the funding of HIV treatment that could stop the spread of HIV, saving the NHS millions of pounds.

Published
11 April 2019
From
Tower Hamlets council
How mass rape in genocide transformed Rwanda's response to AIDS

Rwanda is this week commemorating the 25th anniversary of a dark chapter of human history: a time when extremist ethnic Hutus slaughtered more than 800,000 Tutsis and moderate Hutus - one tenth of the population - over three months. About 250,000 mostly Tutsi women were raped by Hutu government soldiers and allied extremist militia. And as a result, about one in four victims contracted the HIV/AIDS virus.

Published
11 April 2019
From
Reuters

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.